Why Wegovy Makes You Hungry (and What to Do About It)

The end-of-dose dip: why hunger often rises before your next injection

Semaglutide has a half-life of roughly a week, which is why a once-weekly injection is enough to maintain steady-state levels. The practical consequence is that drug concentrations (and therefore appetite suppression) are highest in the day or two after your injection and lowest just before the next one. Many people notice this as a gradual return of hunger towards days five, six or seven of the weekly cycle. If you inject on a Saturday morning, you might find Friday evening genuinely difficult. That pattern is pharmacological, not a failure of willpower or a sign the medicine has stopped working.

The NHS guidance on semaglutide confirms this cyclical picture is consistent with how the drug behaves. Keeping your injection day fixed rather than letting it drift by a day here and there can reduce how pronounced the trough feels. Some people find that scheduling their injection on a day when they are busy (and not home near the kitchen) makes the tail-end of the week easier to manage.

If the dip is very marked or the hunger in those final days is genuinely disruptive, that is worth recording and sharing with your prescriber, and our page on why semaglutide makes some people hungry explains the mechanisms in more detail. It may simply be a timing nuisance, or it may inform a conversation about dose or dose timing.

Is hunger telling you the dose is no longer right for you?

The licensed maintenance dose for Wegovy is 2.4mg weekly, though a higher 7.2mg dose has now received MHRA approval for adults with a BMI of 30 or above. If you have been at 2.4mg for some time and notice that hunger has returned consistently (not just in the pre-injection window) it is reasonable to ask whether your dose has become less effective over time, and our page on whether Wegovy can make you hungry explores why that happens for some people. Some people experience a gradual attenuation of appetite suppression at a given dose, particularly after several months.

This is the kind of clinical question that belongs in a consultation with your prescriber, not a decision to make on your own. Changing dose, timing or treatment requires a proper assessment. If you are reading this because you are already on treatment through another service and feel your concerns are not being heard, our contact page explains how to reach the team.

For context on how the two available semaglutide injection doses compare and what the MHRA's approval of 7.2mg means in practice, the Wegovy overview page covers the full picture.

What you eat changes how hungry Wegovy makes you feel

Semaglutide slows gastric emptying and reduces the speed at which the stomach signals fullness; it does not rewrite which nutrients your body uses to stay satisfied. Meals that are high in refined carbohydrates and low in protein tend to be digested and absorbed relatively quickly, leaving the stomach empty sooner. That means a small bowl of cereal or a piece of toast might leave you genuinely hungry within an hour or two, even at a therapeutic dose of semaglutide.

Protein is the macronutrient most consistently linked to satiety signals in research on appetite regulation, and it becomes especially important on GLP-1 treatment because total food intake is lower and the risk of losing muscle alongside fat is real. Prioritising protein at each meal (eggs, fish, chicken, pulses, Greek yoghurt) is practical and consistent with NHS Better Health guidance on healthy eating for weight loss. Fibre-rich vegetables add bulk without dramatically increasing calories, which helps with the physical sensation of fullness.

For specific guidance on structuring meals while on semaglutide, the page on what to eat on Wegovy goes into considerably more detail. And if you want to understand why some people on semaglutide report almost no appetite at all while others feel relatively little change, our page exploring what it means to feel hungry on Wegovy looks at that individual variation in depth.

When to talk to your prescriber rather than waiting it out

Most hunger on Wegovy is either the end-of-dose dip, a dietary pattern issue, or a normal feature of the titration phase, the period when your body is still adjusting to each new dose. During titration, the gastrointestinal side effects tend to dominate and appetite suppression can feel inconsistent. That usually settles.

The decision this page is built around is: when does persistent hunger warrant clinical input rather than a dietary tweak? A few markers are worth noting. If hunger has been consistently high for more than three weeks at a stable dose, that is worth flagging. If you have not lost any weight over two or three months despite following the programme, the medicine may not be working adequately for you. And if hunger is accompanied by other changes (persistent nausea that has returned, or significant fatigue) those also need clinical review rather than self-management.

Semaglutide is a prescription-only medicine regulated by the MHRA; decisions about whether it is working, whether to continue, and whether anything should change sit with a qualified prescriber. The FAQs page addresses some of the most common questions about treatment review. If you are still deciding whether semaglutide or tirzepatide might suit you better, the weight-loss treatments overview sets out both options honestly. Pricing for private treatment, including what a single transparent cost covers, is explained on the Wegovy cost page.

For anyone still working out whether Wegovy is the right fit, our prescribers carry out a same-day clinical review of every free consultation, a real clinician reads your answers, not a decision tree. If that sounds like a sensible next step, you can start your free consultation today.